Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
JCSE01 - Perspectives for Lung Cancer Early Detection
- 07:30 - 11:15
- 9/23/2018
- Location: Room 202 BD
- Type: Joint IASLC/CSCO/CAALC Session
- Track: Screening and Early Detection
-
+
JCSE01.19 - ALTER-0303 Study: Tumor Mutation Index (TMI) For Clinical Response to Anlotinib in Advanced NSCLC Patients at 3rd Line
11:15 - 11:15 | Presenter: Baohui Han | Author(s): Jun Lu, Wei Zhang, Bo Yan, Lele Zhang, Jie Qian, Bo Zhang, Shuyuan Wang
- Abstract
Loading... -
+
JCSE01.21 - Different Responses to Osimertinib in Primary and Acquired EGFR T790M-Mutant NSCLC Patients
11:15 - 11:15 | Presenter: Shuyuan Wang | Author(s): Bo Zhang, Baohui Han
- Abstract
Loading...
-
+
MA01 - Early Stage Lung Cancer: Questions and Controversies
- 10:30 - 12:00
- 9/24/2018
- Location: Room 202 BD
- Type: Mini Oral Abstract Session
- Track: Treatment of Early Stage/Localized Disease
-
+
MA01.01 - Proposal on Incorporating Lymphovascular Invasion as a T-Descriptor for Stage I Non-Small Cell Lung Cancer
10:30 - 10:35 | Presenter: Shuyuan Wang | Author(s): Bo Zhang, Jianlin Xu, Rong Qiao, Baohui Han, Bo Yan, Yu Dong
- Abstract
Loading...
-
+
OA07 - Oligometastasis: What Should Be the State-Of-The-Art?
- 15:15 - 16:45
- 9/24/2018
- Location: Room 107
- Type: Oral Abstract Session
- Track: Oligometastatic NSCLC
-
+
OA07.06 - Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring EGFR Mutations.
16:10 - 16:20 | Presenter: Fang Hu | Author(s): Jianlin Xu, Bo Zhang, Changhui Li, Wei Nie, Ping Gu, Ping Hu, Huimin Wang, Yujun Zhang, Yinchen Shen, Shuyuan Wang, Baohui Han, Xueyan Zhang
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-107 - The Impact of Anlotinib on Quality of Life in Patients with Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)
16:45 - 18:00 | Presenter: Li Zhang | Author(s): Xiaoyan Si, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Baohui Han, Kai Li, Qiming Wang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Weiqiang Chen, Xiuwen Wang, Yi Luo, Kejun Nan, Faguang Jin, Baolan Li, Yinlan Chen, Jianying Zhou, Donglin Wang
- Abstract
Loading... -
+
P1.01-108 - Management of Anlotinib-Related Adverse Events: Data From ALTER 0303
16:45 - 18:00 | Presenter: Li Zhang | Author(s): Xiaoyan Si, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Baohui Han, Kai Li, Qiming Wang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Weiqiang Chen, Xiuwen Wang, Yi Luo, Kejun Nan, Faguang Jin, Baolan Li, Yinlan Chen, Jianying Zhou, Donglin Wang
- Abstract
Loading... -
+
P1.01-29 - Crizotinib in Advanced Lung Adenocarcinoma Patients with ALK or ROS-1 Rearrangement: Is it the Same?
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Bo Zhang, Jianlin Xu, Yanwei Zhang, Xueyan Zhang, Tianqing Chu, Shuyuan Wang, Rong Qiao, Jie Qian, Jun Lu, Lele Zhang
- Abstract
Loading... -
+
P1.01-30 - Crizotinib in Advanced Non-Adenocarcinoma, NSCLC (NA-NSCLC) Patients with ALK Rearrangement: A Retrospective Study and Literature Review
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Bo Zhang, Yanwei Zhang, Jianlin Xu, Xueyan Zhang, Tianqing Chu, Shuyuan Wang, Jie Qian, Rong Qiao, Jun Lu, Lele Zhang
- Abstract
Loading...
-
+
P1.03 - Biology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.03-05 - Transcriptome Landscape of Lung Adenocarcinoma Patients Revealed Distinct Trajectory Patterns
16:45 - 18:00 | Presenter: Yuqing Lou | Author(s): Yanwei Zhang, Jianlin Xu, Wei Zhang, Xueyan Zhang, Rong Li, Baohui Han
- Abstract
Loading... -
+
P1.03-16 - Anlotinib Inhibits Angiogenesis of Refractory Advanced Non-Small Cell Lung Cancer via Blocking CCL2 Expression
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Jun Lu, Hua Zhong, Tianqing Chu, Xueyan Zhang, Rong Li, Jiayuan Sun, Runbo Zhong, Yuqing Yang, Mohammad Shah Alam, Yuqing Lou, Jianlin Xu, Yanwei Zhang, Jun Wu, Xiaowei Li, Xiaodong Zhao, Kai Li, Liming Lu
- Abstract
Loading... -
+
P1.03-22 - MiR-125b Plays a Tumor Suppressor Role in Inflammation-Related Non-Small Cell Lung Cancer via Repressing IGF-1 Signal Pathway
16:45 - 18:00 | Presenter: Yanwei Zhang | Author(s): Yuqing Lou, Beibei Sun, Xueyan Zhang, Baohui Han
- Abstract
Loading... -
+
P1.03-30 - The Number of Mutated Repair Genes as Predictor for Tumor Mutation Burden of Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Yuqing Lou | Author(s): Yanwei Zhang, Jianlin Xu, Xueyan Zhang, Wei Zhang, Rong Li, Baohui Han
- Abstract
Loading...
-
+
P1.11 - Screening and Early Detection (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.11-19 - Expression of TNFRII in Serum is Correlated with the Significant Risk of Subcentimeter Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Yanwei Zhang | Author(s): Xueyan Zhang, Yuqing Lou, Tianqing Chu, Baohui Han
- Abstract
Loading...
-
+
MA15 - Colliding Approaches - EGFR and Immunotherapy
- 13:30 - 15:00
- 9/25/2018
- Location: Room 107
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
-
+
MA15.07 - Different Responses to Osimertinib in Primary and Acquired EGFR T790M-Mutant NSCLC Patients
14:10 - 14:15 | Presenter: Shuyuan Wang | Author(s): Bo Zhang, Baohui Han
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.01-01 - The Impact of Anlotinib on Brain Metastases of NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)
16:45 - 18:00 | Presenter: Wenhua Liang | Author(s): Yi Zhao, Yalei Zhang, Xi Han, Xinyun Yang, Jianxing He, Kai Li, Baohui Han, - On Behalf Of The Alter0303 Investigators
- Abstract
Loading...
-
+
P2.03 - Biology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.03-22 - OCT4&SOX2 Specific CTLs Plus PD-1 Inhibitor Had Synergistic Effect on Killing CSC And Treating Drug-Resistant Lung Cancer Mice
16:45 - 18:00 | Presenter: Fang Hu | Author(s): Xueyan Zhang, Xiaoxuan Zheng, Bo Zhang, Huimin Wang, Guangyu Tao, Jianlin Xu, Yanwei Zhang, Baohui Han
- Abstract
Loading... -
+
P2.03-37 - The Efficiency of Octamer-4 Specific Cytotoxic T Cells Induce By CD40-B Cells in Killing Lung Cancer Stem-Like Cells
16:45 - 18:00 | Presenter: Fang Hu | Author(s): Xueyan Zhang, Jianlin Xu, Huimin Wang, Xiaoxuan Zheng, Yanwei Zhang, Yuqing Lou, Baohui Han
- Abstract
Loading...
-
+
P2.11 - Screening and Early Detection (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.11-01 - Blood Transcriptomics Enables Detection of Pre-Invasive & Minimally-Invasive Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Fangfei Qian, Wenjia Yang, Xiang Zuo, Jie Qian, Bo Zhang, Shuyuan Wang, Lele Zhang
- Abstract
Loading...